论文部分内容阅读
每年约有 6%的肝硬化和稍低于此百分比的慢性肝炎病人发生肝癌 ,本研究旨在确定诊断肝癌的甲胎蛋白 (ＡＦＰ)和ＰＩＶＫＡ Ⅱ (异常凝血酶原 )的临界水平 ,并用以筛检病人。材料与方法 73 4例患者年龄 2 4～ 84岁。其中 3 5 3例诊断为慢性肝炎 (ＣＨ) (5 0 %由乙型肝炎病毒
About 6% of liver cirrhosis patients and a little lower than this percentage of chronic hepatitis patients develop liver cancer each year. This study was designed to determine the critical levels of alpha-fetoprotein (AFP) and PIVKA II (abnormal prothrombin) in the diagnosis of liver cancer. Screening patients. Materials and Methods 73 Four patients were 24 to 84 years old. Of these, 343 cases were diagnosed as chronic hepatitis (CH) (50% were infected with hepatitis B virus